Literature DB >> 26420372

Characteristics of Travelers to Asia Requiring Multidose Vaccine Schedules: Japanese Encephalitis and Rabies Prevention.

Xaviour J Walker1, Elizabeth D Barnett2, Mary E Wilson3, William B Macleod4, Emily S Jentes5, Adolf W Karchmer6,7, Davidson H Hamer4,8, Lin H Chen7,9.   

Abstract

BACKGROUND: Japanese encephalitis (JE) and rabies are serious vaccine preventable diseases which are an important consideration for travelers to Asia.
METHODS: Five Boston-area travel clinics collected demographic data, trip information, and interventions for travelers to Asia seen at pre-travel consultations from March 1, 2008, through July 31, 2010. We evaluated travelers for proportion vaccinated for JE and rabies, those traveling for >1 month, and whether travelers had adequate time to complete the JE series (clinic visit ≥28 days before departure) and rabies pre-exposure prophylaxis (clinic visit ≥21 days before departure).
RESULTS: Among 15,440 travelers from five Boston Area Travel Medicine Network travel clinics, Asia was the most common destination region, visited by 5,582 (36%) of travelers. Among these travelers, 4,810 (86%) planned to travel to only one Asian subregion. Median trip duration was 17 days, with more than 20% traveling for >1 month. The most common destinations were South (41%), Southeast (26%), and East (23%) Asia. Of those traveling to South, Southeast, or East Asia, over one-third with trips >1 month had insufficient time to complete a series for either JE or rabies vaccine. Overall, only 10% of travelers were vaccinated (past and pre-travel visit) for either JE or rabies, with lowest percentages among travelers visiting friends and relatives. Most travelers received advice on vector precautions (96%) and rabies prevention, which included avoiding animal contact, washing wounds, and obtaining appropriate post-exposure prophylaxis (88%).
CONCLUSION: Given the insufficient time for completion and relatively low vaccination rates, greater awareness of earlier pre-travel consultations, at least 4-6 weeks before travel, and accurate risk assessment for travelers are important. Effective counseling about vector avoidance, rabies, and animal bite prevention and management remains critical.
© 2015 International Society of Travel Medicine.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26420372     DOI: 10.1111/jtm.12237

Source DB:  PubMed          Journal:  J Travel Med        ISSN: 1195-1982            Impact factor:   8.490


  4 in total

1.  Traveller exposures to animals: a GeoSentinel analysis.

Authors:  Michael P Muehlenbein; Kristina M Angelo; Patricia Schlagenhauf; Lin Chen; Martin P Grobusch; Philippe Gautret; Alexandre Duvignaud; François Chappuis; Kevin C Kain; Emmanuel Bottieau; Loïc Epelboin; Marc Shaw; Noreen Hynes; Davidson H Hamer
Journal:  J Travel Med       Date:  2020-11-09       Impact factor: 8.490

2.  Rabies post-exposure prophylaxis started during or after travel: A GeoSentinel analysis.

Authors:  Philippe Gautret; Kristina M Angelo; Hilmir Asgeirsson; David G Lalloo; Marc Shaw; Eli Schwartz; Michael Libman; Kevin C Kain; Watcharapong Piyaphanee; Holly Murphy; Karin Leder; Jean Vincelette; Mogens Jensenius; Jesse Waggoner; Daniel Leung; Sarah Borwein; Lucille Blumberg; Patricia Schlagenhauf; Elizabeth D Barnett; Davidson H Hamer
Journal:  PLoS Negl Trop Dis       Date:  2018-11-13

3.  Characteristics and preparation of the last-minute traveler: analysis of vaccine usage in the Global TravEpiNet Consortium.

Authors:  Johnnie A Yates; Sowmya R Rao; Allison Taylor Walker; Douglas H Esposito; Mark Sotir; Regina C LaRocque; Edward T Ryan
Journal:  J Travel Med       Date:  2019-09-02       Impact factor: 8.490

4.  Pretravel Health Preparation of International Travelers: Results From the Boston Area Travel Medicine Network.

Authors:  Davidson H Hamer; William B MacLeod; Lin H Chen; Natasha S Hochberg; Laura Kogelman; Adolf W Karchmer; Winnie W Ooi; Christine Benoit; Mary E Wilson; Emily S Jentes; Elizabeth D Barnett
Journal:  Mayo Clin Proc Innov Qual Outcomes       Date:  2017-04-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.